First Trimester Down Syndrome Screening Results - Obstetrics and Gynecology

More Info

---

Understanding the results of first-trimester Down syndrome screening can be quite complex, especially when multiple tests yield different results. In your case, the initial screening indicated a higher risk for Down syndrome (greater than 1 in 4), which is concerning. This risk assessment is based on several factors, including the absence of a nasal bone, the measurement of nuchal translucency (NT) at 2.5 mm, and elevated blood test markers.
The absence of a nasal bone is a significant marker in first-trimester screenings, as it is often associated with an increased risk of chromosomal abnormalities, including Down syndrome. Nuchal translucency is another critical measurement; a thickness greater than 3 mm is typically considered abnormal, but a measurement of 2.5 mm is still above the average range and may warrant further investigation. Elevated levels of certain blood markers can also indicate a higher risk for Down syndrome, which is why your healthcare provider is taking these findings seriously.

However, the fact that you also underwent a non-invasive prenatal testing (NIPT) and received a low-risk result is encouraging. NIPT is a highly sensitive and specific test that analyzes fetal DNA circulating in the mother's blood. It is known for its accuracy in detecting Down syndrome and other chromosomal abnormalities. A low-risk result from NIPT generally suggests that the likelihood of the fetus having Down syndrome is significantly reduced, although it does not completely eliminate the risk.

Given this conflicting information, the decision to proceed with invasive testing such as amniocentesis (often referred to as "羊膜穿刺" in Mandarin) should be carefully considered. Amniocentesis carries a small risk of miscarriage (about 1 in 300 to 1 in 500), so it is typically recommended when the risk of a chromosomal abnormality is deemed high enough to warrant the potential risks of the procedure.
In your case, since the initial screening indicated a high risk but was followed by a low-risk NIPT result, it may be beneficial to discuss the following with your healthcare provider:
1. Risk Assessment: Ask your doctor to explain the implications of both the first-trimester screening and the NIPT results. Understanding how these tests correlate can help clarify the overall risk for your baby.

2. Further Testing: Discuss the necessity of amniocentesis in light of the NIPT results. Your doctor may suggest it if they believe the initial screening results are concerning enough to warrant further investigation.

3. Counseling: Consider genetic counseling, which can provide you with more information about the risks, benefits, and limitations of further testing options, including amniocentesis and chorionic villus sampling (CVS).

4. Monitoring: If you choose not to undergo invasive testing, your healthcare provider may recommend additional monitoring through ultrasounds or follow-up screenings later in the pregnancy to assess fetal development.

Ultimately, the decision to proceed with amniocentesis or any further testing should be made collaboratively with your healthcare provider, taking into account your personal values, concerns, and the medical information available. It's essential to feel comfortable and informed about the choices you make during this critical time in your pregnancy.